51 |
NF-kB c-Rel in Fibroblasten und Fibrose / NF-kB c-Rel in fibroblasts and fibrosisTrautschold-Krause, Franziska Susanne 13 August 2020 (has links)
No description available.
|
52 |
IDENTIFICATION OF SUMOYLATED PROTEINS AND INVESTIGATION OF PROTEIN UBIQUITINATION IN THE NF-κB PATHWAYLiu, Xiaoyan 01 January 2012 (has links)
SUMOylation and ubiquitination are important post-translational modifications. While ubiquitination is well known for targeting proteins for degradation, SUMOylation often regulates the intracellular localization of substrates. In the first project of this dissertation, we developed proteomic strategies to identify novel SUMOylated proteins in mammalian cells. In the second project, we investigated the regulation of protein ubiquitination in the NF-κB signaling pathway in the context of Paget’s disease of bone (PDB).
Identification of SUMOylated proteins has been a challenge because of low abundance of SUMOylation substrates. Here, we utilized a mass spectrometry (MS)-based proteomic approach to identify novel SUMOylated proteins in mammalian cells. Seventy-four unique proteins were commonly identified in the collection of four SUMO-1 plasmids, thus considered candidate SUMOylated proteins. Many of these proteins are associated with the nucleus. The results were validated by confirming SUMOylation of a novel substrate Drebrin and a well known substrate Ran-GAP1. Furthermore, the potential SUMOylation sites in Drebrin have been identified and confirmed using site-directed mutagenesis.
PDB is a disorder characterized by increased bone turnover containing hyperactive osteoclasts. Mutations in Sequestosome 1 (p62) are associated with 40% of familial PDB. P62 is a scaffold protein and plays a critical role in regulating ubiquitination of TRAF family signaling molecules and mediating the activation of NF-κB by RANK and TNFα ligands. P62 also plays a critical role in shuttling substrates for autophagic degradation. The objective of this project is to determine the effects of PDB-associated p62 mutants on NF-κB signaling and autophagy. We compared the effect of wild-type (WT) p62 and PDB mutations (A381V, M404V and P392L) on the TNFα-induced NF-κB signaling using an NF-κB luciferase assay. Our results show that these p62 mutations increased the NF-κB signaling. In addition, we found that the PDB mutations did not change the interaction between p62 and the autophagy marker protein LC3. In summary, the PDB mutations in p62 are likely gain-of-function mutations that can increase NF-κB signaling and potentially contribute to disease progression. Based on the results, we proposed a model to speculate the synergetic role of p62 PDB mutant on NF-κB signaling and autophagy.
|
53 |
Rôle du récepteur REG/EXTL3 dans l’inflammation et son implication possible dans l’ostéoarthrose (OA)Boiro, Mamadou S. 07 1900 (has links)
L’ostéoarthrose (OA) est une maladie articulaire dont l’incidence augmente avec le vieillissement de la population. Elle se caractérise par une détérioration progressive du cartilage articulaire accompagnée du remodelage de l’os sous-chondral et du changement des tissus mous de l’articulation. La douleur et le dysfonctionnement de l’articulation affectée sont généralement attribués à l’inflammation et l’épanchement de la synovie. Plusieurs évidences indiquent que l’inflammation de la membrane synoviale contribue grandement à la pathogenèse de l’OA. En effet, la synthèse et l’expression des enzymes protéolytiques qui dégradent la matrice cartilagineuse sont régulées par de nombreuses cytokines retrouvées au sein de ce foyer inflammatoire. Deux d’entre elles, l’interleukine-1 beta (IL-1β) et le «tumor necrosis factor » alpha (TNF-α), jouent un rôle majeur dans le déclenchement de l’inflammation associée à l’OA. Ces cytokines pro-inflammatoires agissent notamment sur les synoviocytes et les chondrocytes en activant NF-κB qui, à son tour, active les gènes de cytokines. Cette boucle de régulation positive amplifie et perpétue la réponse inflammatoire. Récemment, il a été rapporté que l’activation de NF-κB par TNF-α peut être potentialisée par EXTL3, un récepteur transmembranaire ; mais le mécanisme sous-jacent de cet effet demeure inconnu. Toutefois, les niveaux important d’EXTL3 et de son ligand Reg1B chez les patients arthrosiques, laissent croire que ces protéines jouent un rôle dans le développement de l’OA.
Notre objectif était d’étudier le mécanisme par lequel EXTL3 amplifie l’activation de NF-κB par TNF-α et d’examiner si ce phénomène se produit aussi avec l’IL-1β. Nous avons utilisé les cellules C28/I2, une lignée cellulaire de chondrocytes, comme modèle d’étude. Les transfections transitoires avec un vecteur d’expression, les techniques d’immunofluorescence (IF), d’immunoprécipitation (IP) et d’immunobuvardage de type Western (IB); ont été utilisées dans le cadre de diverses approches expérimentales. Les résultats obtenus par transfection ont révélé que la protéine EXTL3 potentialisait l’activation de NF-κB aussi bien par IL-1β que par TNF-α. Ce résultat signifie que la potentialisation de l’activité NF-κB par EXTL3 n’est pas spécifique à TNF-α. D’autre part, l’IP avec TNFRI et TRAF2 a révélé la présence d’EXTL3 dans le complexe TNF-α/TNFRI/TRAF2 qui se forme au niveau de la membrane plasmique. De plus, ceci a été confirmé in vivo par microscopie confocale montrant la co-localisation de TNFRI-TRAF2-EXTL3 dans la membrane nucléaire, suggérant ainsi la formation d’un complexe identique au niveau des membranes plasmique et nucléaires. Toutefois, la présence du ligand Reg1B et/ou de la glucosamine inhibait la formation de ce complexe au niveau de la membrane plasmique, tout comme ils abolissaient la potentialisation de l’activité NF-κB par EXTL3. Ces résultats suggèrent non seulement que le recrutement d’EXTL3 libre dans le complexe TNF-α/TNFR1 est requis pour amplifier l’activation de NF-κB par TNF-α, mais aussi la capacité du ligand Reg1B et de la glucosamine à moduler cette activation à travers la baisse ou l’inhibition de l’interaction EXTL3-TNFR1.
Les données de cette étude constituent une avancée majeure dans la compréhension des événements moléculaires qui contrôlent l’activation de NF-κB par les cytokines pro-inflammatoires. Ces résultats pourraient conduire au développement de nouvelles approches thérapeutiques pour le traitement de l’inflammation associée à l’OA et impliquant une activation incessante de NF-κB. / Osteoarthritis (OA) is an articular disease with a particularly high incidence in the elderly. This disease is characterized by the progressive degeneration of the cartilage followed by subchondral bone remodelling and a change in the soft tissues of the joint. Local chronic pain and joint malfunction are generally attributed to the inflammation of the synovial membrane, which in itself has been shown to significantly contribute to the pathogenesis of OA. In fact, the synthesis and expression of many proteolytic enzymes which degrade cartilage matrix are regulated by numerous cytokines originating from these inflammation sites. Two pro-inflammatory cytokines, the tumor necrosis factor alpha (TNF-α) and the interleukine-1β (Il-1β), play a major role in triggering inflammation associated with OA. These cytokines act on synoviocytes and chondrocytes by activating the transcription factor NF-κB, which in turn activates the cytokines’ genes. This positive regulating loop amplifies and maintains inflammatory responses. Recently, studies have shown that the over-expression of the REG receptor/EXTL3, a transmembranous receptor, enhances the activity of cytokine TNF-α in the activation of NF-κB. Unfortunately the mechanism involved in this process is still unknown. In addition, levels of EXTL3 and its ligand REG1B observed in OA patients suggest their possible involvement in the development of OA.
Our goal was to study and elucidated the mechanisms used by EXTL3 to amplify NF-κB activation by TNF-α, as well as to examine whether the same phenomenon is occurring with IL-β. A human chondrocytes cell line called C28/I2 as experimental model. The techniques used for the current study were transfection assays, immunoflorescence (IF), immunoprecipitation (IP), and Western blotting (WB). Our transfection data have shown that EXTL3 was able to enhance NF-κB activity induced by TNF-α as well as by IL-1β. This result suggests that the enhanced NF-κB activity by EXTL3 is not specific to TNF-α. The IP experiments with TNFR1 and TRAF2 revealed the presence of EXTL3 in TNF-α/TNFR1 complex which is formed in the plasma membrane. Also, IF assay in combination with confocal microscopy allowed us to detect TNFR1/TRAF2/EXTL3 co-localisation on the nuclear membrane, suggesting the formation of TNF-α/TNFR1 complex on both the nuclear and plasma membranes. Somehow, REG1B, an EXTL3 ligand, and glucosamine were able to inhibit the formation of this complex at the plasma membrane. They were also able to abolish NF-κB activity enhanced by EXTL3. These results suggest that not only EXTL3 recruitment in the TNF-α/TNFR1 complex is required to amplify NF-κB activation by TNF-α, but also that REG1B ligand and glucosamine have the ability to modulate this activation by reducing or inhibiting EXTL3 and TNFR1 interactions.
This study’s data represents a major advance in the understanding of molecular events controlling NF-κB activation by pro-inflammatory cytokines. These results could lead to the development of new therapeutics targets, in the treatment of disorders associated to OA and involving recurrent activation of NF-κB.
|
54 |
ALTERNATIVELY ACTIVATED MACROPHAGES IN <em>PSEUDOMONAS AERUGINOSA</em> PNEUMONIA: MODULATION OF THE NF-ΚB SIGNALING PATHWAY AND THE IMMUNOMODULATORY ROLE OF ARGINASE-1Haydar, Dalia 01 January 2018 (has links)
Background: Azithromycin polarizes macrophages into an alternative phenotype and promotes a regulated immunity. Arginase is an important effector of these macrophages believed to play an essential role in decreasing injury and promoting repair.
Hypothesis: Decreases in inflammation in response to Pseudomonas aeruginosa (PA) pneumonia achieved by polarizing macrophages to an alternative phenotype is dependent upon the production of arginase.
Methods: Requirement of arginase was examined by pharmacological inhibition using S-(2-boronoethyl)- l-cysteine (BEC) or l-norvaline and by infecting arginase-1 conditional knock-out mice (Arg1flox/flox;Lyz2-cre (Arg1Δm)) with PA intratracheally. Arg1ΔM and control Arg1flox/flox mice were then dosed with azithromycin daily via oral gavage beginning four days prior to infection. Analysis of weight loss in addition to characterization of inflammatory cells and cytokine production via flow cytometry was performed. Macrophages were then stimulated with LPS and polarized with IL4/13, IFNγ, or azithromycin plus IFNγ. Western blot for signaling mediators, p65 translocation assay, and immunofluorescence were performed.
Results: Myeloid arginase-1 deletion resulted in greater morbidity along with more severe inflammatory response compared to the Arg1flox/flox mice. Arg1Δm mice had greater numbers of neutrophils, macrophages, and lymphocytes in their airways and lymph nodes compared to the Arg1flox/flox mice. Conversely, global arginase inhibition resulted in greater weight loss along with greater neutrophil and macrophage infiltration compared to Arg1Δm mice. BEC and l-norvaline treated mice had higher numbers of lymphocytes in their lymph nodes with variable effects on airway lymphocyte counts. Azithromycin treatment comparably reduced the acute inflammatory responses in both Arg1Δm and Arg1flox/flox mice. To evaluate this mechanism, we show in vitro that azithromycin decreases NF-κB activation by preventing p65 nuclear translocation and by decreasing STAT1 activation in a concentration-dependent manner. These effects were reversed with IKKβ inhibition.
Conclusions: Myeloid arginase is essential for control of inflammatory responses in PA pneumonia with potentially different effects of other cellular sources demonstrated with global arginase inhibition. Azithromycin reduces excessive inflammation even in the absence of arginase, potentially through a cross-inhibitory mechanism involving STAT1 and NF-κB pathways through IKKβ.
|
55 |
Regulation of NF-κB by CalmodulinAntonsson, Åsa January 2003 (has links)
<p>Cells experience numerous external signals which they must respond to. Such signals arriving at the cell surface are transduced via various signal transduction pathways and often ultimately result in regulation of transcription. NF-κB is a family of transcription factors involved in the regulation of genes important for processes such as immune and inflammatory responses, cell growth, development and cell survival. NF-κB proteins are normally kept inactive in the cytoplasm due to masking of their nuclear localisation signal (NLS) by inhibitory IκB proteins. A large number of stimuli lead to the activation of IκB-kinase (IKK). Active IKK phosphorylates IκB and thereby labels it for ubiquitination and, subsequently, degradation by the proteasome. Liberated NF-κB enters the nucleus, where it takes part in the regulation of its target genes. </p><p>Calmodulin (CaM) is a ubiquitous Ca2+-binding protein which is considered to be the predominant intracellular Ca2+ sensor. CaM plays a major role in the Ca2+-dependent regulation of a wide variety of cellular processes, including transcription. CaM regulates transcription both indirectly through CaM-dependent kinases and phosphatases and directly through interaction with transcription factors.</p><p>CaM was found to bind directly and in a Ca2+-dependent fashion to the two NF-κB family members c-Rel and RelA. The CaM-NF-κB interactions were strongly enhanced by NF-κB activating stimuli and this enhancement was blocked by the addition of IκB, suggesting that c-Rel and RelA can bind CaM after their signal-induced release from IκB. Compared to wild-type c-Rel, CaM binding-deficient mutants were shown to exhibit an increased nuclear accumulation and transcriptional activity on Ca2+-regulated cytokine promoters. The results suggest that CaM can inhibit transport of c-Rel, but not of RelA, to the nucleus and thereby differentially regulate the activation of NF-κB proteins following cell stimulation. CaM was also found to affect NF-κB activity indirectly through the action of a CaM-dependent kinase (CaMK). Studies of the events leading to IκBα phosphorylation revealed that CaM and CaMKII inhibitors blocked phorbol ester induced activation of IKK. Furthermore, CaM and CaMKII inhibitors also blocked T cell receptor/CD3 induced IκBα degradation, and expression of an inhibitor-resistant derivative of the γ isoform of CaMKII caused the inhibitors lose their effect on phorbol ester induced IκBα degradation. Finally, expression of a constitutively active CaMKII resulted in the activation of NF-κB. These results identify CaMKII as a mediator of IKK activation, specifically in response to T cell receptor/CD3 and phorbol ester stimulation.</p><p>In conclusion, this thesis describes the identification of CaM as a dual regulator of NF-κB proteins, acting both directly and indirectly to affect the activity of this family of transcription factors.</p>
|
56 |
Identification des « Ubiquitin Specific proteases » impliquées dans la régulation des voies de l'immunité chez la drosophileEngel, Elodie 02 July 2009 (has links) (PDF)
La dérégulation des facteurs NF-κB, impliqués dans la survie cellulaire et l'inflammation, peut entraîner des pathologies inflammatoires chroniques et des cancers. Dans ce contexte, l'objectif de ma thèse était d'identifier des régulateurs négatifs des voies NF-κB conservées au cours de l'évolution, Toll et Imd, chez la drosophile. De nombreux éléments de ces voies sont régulés par ubiquitination. Les « Ubiquitine Specific Proteases » (USPs) constituent ainsi un nouveau champ d'investigation pour rechercher des régulateurs de ces voies. J'ai réalisé le crible d'une collection d'ARN interférents permettant l'inactivation des 21 USPs de drosophile en cellules S2. Ce crible a mis en évidence trois régulateurs négatifs de la voie Imd, dont un montre également une activité sur la voie Toll. Parmi ces candidats, dUSP36, un homologue de la protéine humaine USP36, avait été préalablement sélectionné par un crible génétique au laboratoire. Des études de l'équipe auxquelles j'ai contribué, montrent son rôle in vivo dans la régulation négative de la protéine adaptatrice Imd via son activité catalytique. Afin de caractériser la fonction des deux autres USPs, j'ai mené des expériences de transgénèse chez la drosophile qui prouvent que ces deux USPs répriment la voie Imd en cas d'infection et qu'elles sont requises pour maintenir l'état inactif de la voie Imd en l'absence d'infection. J'ai également entrepris de caractériser l'activité catalytique des deux USPs in vitro. L'originalité de mon travail a consisté à limiter le crible à une famille de gènes, ce qui a permis de détecter de nouveaux régulateurs qui n'avaient pas été mis en évidence dans des cribles antérieurs.
|
57 |
Phylogenies and Secondary Chemistry in <i>Arnica</i> (Asteraceae)Ekenäs, Catarina January 2008 (has links)
<p>The genus <i>Arnica</i> (Asteraceae) was investigated for phylogenetic relationships and sesquiterpene lactone (STL) content with the aims to trace the evolutionary history of the genus and to investigate possible congruencies between DNA sequence data, secondary chemistry, and biological activity. </p><p>Complex evolutionary patterns in <i>Arnica</i> are evident from phylogenetic analyses of chloroplast regions (the <i>rpl16</i> and <i>rps16</i> introns and the <i>psbA–trnH</i>, <i>ycf4–cemA</i>, and <i>trnT–L</i> spacers), nuclear ribosomal regions (the internal and external transcribed spacers) and the nuclear low-copy DNA region coding for the second largest subunit of RNA polymerase II (<i>RPB2</i>) between exons 17 and 23. Polymorphism was detected in nuclear ribosomal and low-copy regions<i>,</i> likely caused by polyploidy and agamospermy. Lineage sorting and/or hybridization is a possible explanation for incongruencies between topologies of the different DNA regions. None of the five subgenera in <i>Arnica</i> constitute a monophyletic group according to any of our analyses. </p><p>Sesquiterpene lactone profiles were compared to nuclear ribosomal DNA data using phylogenetic inference and principal component analysis for 33 accessions of 16 species. Clusters supported by both STL chemistry and ribosomal DNA sequence data consist of multiple accessions of the same species (e.g.<i> A montana </i>and<i> A. longifolia</i>), indicating that these species are well defined both genetically and chemically, based on our sampling. Support for subspecies classification of <i>A. chamissonis</i> and <i>A. parryi</i> was found in chemical data. For the first time STLs are reported from subtribe Madiinae, sister to Arniciinae.</p><p>Anti-inflammatory properties, as measured by inhibition of human neutrophil elastase release from neutrophils and inhibition of the binding of transcription factor NF-κB to DNA, were investigated for extracts of 12 <i>Arnica</i> species. <i>Arnica montana</i>, <i>A. chamissonis</i> and <i>A. longifolia</i> accessions show high inhibitory effects in both bioassays. Generally, species with a more diverse STL chemistry also possess the strongest inhibitory activity in the bioassays.</p>
|
58 |
Regulation of NF-κB by CalmodulinAntonsson, Åsa January 2003 (has links)
Cells experience numerous external signals which they must respond to. Such signals arriving at the cell surface are transduced via various signal transduction pathways and often ultimately result in regulation of transcription. NF-κB is a family of transcription factors involved in the regulation of genes important for processes such as immune and inflammatory responses, cell growth, development and cell survival. NF-κB proteins are normally kept inactive in the cytoplasm due to masking of their nuclear localisation signal (NLS) by inhibitory IκB proteins. A large number of stimuli lead to the activation of IκB-kinase (IKK). Active IKK phosphorylates IκB and thereby labels it for ubiquitination and, subsequently, degradation by the proteasome. Liberated NF-κB enters the nucleus, where it takes part in the regulation of its target genes. Calmodulin (CaM) is a ubiquitous Ca2+-binding protein which is considered to be the predominant intracellular Ca2+ sensor. CaM plays a major role in the Ca2+-dependent regulation of a wide variety of cellular processes, including transcription. CaM regulates transcription both indirectly through CaM-dependent kinases and phosphatases and directly through interaction with transcription factors. CaM was found to bind directly and in a Ca2+-dependent fashion to the two NF-κB family members c-Rel and RelA. The CaM-NF-κB interactions were strongly enhanced by NF-κB activating stimuli and this enhancement was blocked by the addition of IκB, suggesting that c-Rel and RelA can bind CaM after their signal-induced release from IκB. Compared to wild-type c-Rel, CaM binding-deficient mutants were shown to exhibit an increased nuclear accumulation and transcriptional activity on Ca2+-regulated cytokine promoters. The results suggest that CaM can inhibit transport of c-Rel, but not of RelA, to the nucleus and thereby differentially regulate the activation of NF-κB proteins following cell stimulation. CaM was also found to affect NF-κB activity indirectly through the action of a CaM-dependent kinase (CaMK). Studies of the events leading to IκBα phosphorylation revealed that CaM and CaMKII inhibitors blocked phorbol ester induced activation of IKK. Furthermore, CaM and CaMKII inhibitors also blocked T cell receptor/CD3 induced IκBα degradation, and expression of an inhibitor-resistant derivative of the γ isoform of CaMKII caused the inhibitors lose their effect on phorbol ester induced IκBα degradation. Finally, expression of a constitutively active CaMKII resulted in the activation of NF-κB. These results identify CaMKII as a mediator of IKK activation, specifically in response to T cell receptor/CD3 and phorbol ester stimulation. In conclusion, this thesis describes the identification of CaM as a dual regulator of NF-κB proteins, acting both directly and indirectly to affect the activity of this family of transcription factors.
|
59 |
Phylogenies and Secondary Chemistry in Arnica (Asteraceae)Ekenäs, Catarina January 2008 (has links)
The genus Arnica (Asteraceae) was investigated for phylogenetic relationships and sesquiterpene lactone (STL) content with the aims to trace the evolutionary history of the genus and to investigate possible congruencies between DNA sequence data, secondary chemistry, and biological activity. Complex evolutionary patterns in Arnica are evident from phylogenetic analyses of chloroplast regions (the rpl16 and rps16 introns and the psbA–trnH, ycf4–cemA, and trnT–L spacers), nuclear ribosomal regions (the internal and external transcribed spacers) and the nuclear low-copy DNA region coding for the second largest subunit of RNA polymerase II (RPB2) between exons 17 and 23. Polymorphism was detected in nuclear ribosomal and low-copy regions, likely caused by polyploidy and agamospermy. Lineage sorting and/or hybridization is a possible explanation for incongruencies between topologies of the different DNA regions. None of the five subgenera in Arnica constitute a monophyletic group according to any of our analyses. Sesquiterpene lactone profiles were compared to nuclear ribosomal DNA data using phylogenetic inference and principal component analysis for 33 accessions of 16 species. Clusters supported by both STL chemistry and ribosomal DNA sequence data consist of multiple accessions of the same species (e.g. A montana and A. longifolia), indicating that these species are well defined both genetically and chemically, based on our sampling. Support for subspecies classification of A. chamissonis and A. parryi was found in chemical data. For the first time STLs are reported from subtribe Madiinae, sister to Arniciinae. Anti-inflammatory properties, as measured by inhibition of human neutrophil elastase release from neutrophils and inhibition of the binding of transcription factor NF-κB to DNA, were investigated for extracts of 12 Arnica species. Arnica montana, A. chamissonis and A. longifolia accessions show high inhibitory effects in both bioassays. Generally, species with a more diverse STL chemistry also possess the strongest inhibitory activity in the bioassays.
|
60 |
Mechanisms of Recombinant Heat Shock Protein 27 Atheroprotection: NF-κB Signaling in MacrophagesSalari, Samira 05 March 2012 (has links)
The O’Brien lab has demonstrated that Heat shock protein 27 (HSP27)shows attenuated expression in human coronary arteries as the degree of atherosclerosis progresses. Moreover, over-expression of HSP27 reduces
atherogenesis in mice. The precise mechanism(s) for HSP27-mediated "atheroprotection" are incompletely understood. Nuclear Factor-kappaB (NF-κB)
is a key signaling modulator in atherogenesis. Hence, this project sought to determine if recombinant HSP27 (rHSP27) alters NF-κB signaling to affect atheroprotection. Treatment of THP1 macrophages with rHSP27 resulted in degradation of IκBα, coincided with nuclear translocation of the p65 subunit and produced transcriptional evidence of activation of NF-κB signaling. When the transcriptional profile of THP1 macrophages treated with rHSP27 was analyzed using NF-κB-pathway-specific qRT-PCR arrays, among the regulated genes, IL-10 and GM-CSF mRNA levels were markedly increased, as were parallel translational effects observed. These data provide new mechanistic insights into the atheroprotective effects of HSP27.
|
Page generated in 0.0256 seconds